Improving treatment outcomes for malignant mesothelioma patients using biomarkers. [ 2014 - 2017 ]

Research Grant

Researchers: Prof Jenette Creaney (Principal investigator) ,  Prof Anna Nowak ,  Prof Arthur Musk ,  Prof Bruce Robinson ,  Prof Steve Skates

Brief description The deadly asbestos-induced cancer mesothelioma is continuing to kill tens of thousands of people each year. Most patients are diagnosed with advanced disease. In this study we will use novel biomarkers to help the diagnosis of mesothelioma and potentially improve treatment options for patients.

Funding Amount $AUD 795,262.15

Funding Scheme Project Grants

Notes Standard Project Grant